Undruggable Drugs
In this episode of the a16z Podcast, we take a deep dive into the world of drug development—specifically “undruggable drugs”: a category of protein, protein family or even piece of RNA that’s so difficult to target that many researchers don’t even want to touch it. Jay Bradner, President of the Novartis Institute for BioMedical Research,...
Faster Science, Better Drugsa16z.com
Mark Cuban on the NBA, Cost Plus Drugs, and How to Fix Politicsa16z.com
Raghu Raghurama16z.com
The Little Tech Agendaa16z.com
Engaging the Unengaged at Home with Max Cohen and Cameron Behara16z.com
Evolve or Die: The Future of the Creative Process, Artist Authenticity, and the Value of the Musica16z.com
Trump pardons Silk Road creator Ross UlbrichtTechcrunch
How this simulations software production team halved their video delivery time using HeyGenHeygen
AssemblyAI Medical Mode for Clinical DictationAssemblyai
AI Corrects 50 Years of Sex Bias in Drug Safety TrialsThenewstack
China Races to Build Record Biobank to Rival US Drugs Researchcset.georgetown.edu
2024 Big Ideas: Miracle Drugs, Programmable Medicine, and AI Interpretabilitya16z.com
The Consolidated Drug Channel and Cash-Pay Drugs with Adam Feina16z.com
Drugging the Undruggable with Greg Verdinea16z.com
16 Minutes on the News #28: Drugs & Debates — Real World Data, Randomized Controlled Trialsa16z.com
Using CRISPR to Prevent Coronavirus and Influenza Infectiona16z.com
Journal Club: A New Path to Antibiotic Resistancea16z.com
Journal Club: Engineering Living Materialsa16z.com
Journal Club: A Safer Psychedelica16z.com
Robin Automates Drug Discovery, Matching Chemical Processes of Known Drugs to Research on Diseasesdeeplearning.ai
